Efficacy Skincare OEM: Capturing Hundred-Billion Dividend

For the past two years, the friends around me building skincare brands have asked one question more than any other: "Can we still get into this track?" My answer is usually direct — the efficacy skincare OEM track is far from its ceiling. In fact, precisely because regulation is tightening and consumers are getting savvier, it has entered a phase of "professionals eat the meat while the amateurs share the broth." According to data from agencies such as QYResearch, the global skincare contract-manufacturing revenue reached about RMB 65.18 billion in 2025 and will approach RMB 108.74 billion by 2032, a CAGR of 7.5% — firmly stepping onto the hundred-billion tier. China's efficacy skincare market, already around RMB 128 billion in 2025, has grown at a five-year CAGR of roughly 21.3%, clearly outpacing the broader skincare market. The pie is growing, but how you slice it has changed.

I. Behind the hundred-billion track: why is efficacy skincare so hot?

Let's put a few numbers out first, to judge whether the trend is real: efficacy skincare's share of the overall skincare market rose from about 22% in 2020 to roughly 34% in 2025; the industry widely expects China's efficacy skincare market to surpass RMB 200 billion by 2028. At the same time, China's industry itself keeps growing at double digits — from RMB 21.4 billion in 2017 to RMB 39.4 billion in 2021, and further to about RMB 62.3 billion between 2022 and 2025.

The growth did not come from nowhere. A often-overlooked backdrop: after the new regulatory regulations took effect in 2021, efficacy claims must be backed by scientific evidence. That rule shut out a large wave of label-only products that merely told stories, and instead opened space for contract manufacturers with real R&D and testing capability. Consumers were also "educated" into it — ingredient explainers on Xiaohongshu and Douyin pushed words like niacinamide, pro-Xylane and recombinant collagen into ordinary shoppers' carts, and checking the ingredient list before buying became a new habit.

II. Three growth drivers: the ingredient-savvy consumer and real demand

In terms of concrete demand, the heat around efficacy skincare breaks into three threads, each backed by a real consumer pain point:

1. Ingredient-savvy consumers turned "scientific skincare" into consensus

Today's consumers no longer just trust a big-brand logo — they trust ingredients, concentrations and mechanisms. For anti-aging they look at pro-Xylane and peptides; for brightening, niacinamide, tranexamic acid and arbutin; for repair, ceramides, centella and ectoin. A brand without formula expertise will struggle to speak to this crowd — and that is exactly where the contract manufacturer adds value.

2. Anti-aging, brightening and repair: the three horsepower

Anti-aging demand has trickled down from middle-aged consumers to the "early-aging anxiety" of the 25+ group; brightening has evolved from simple illumination to the precise ask of "spot-fading + even skin tone"; and repair is propped up by the sensitive-skin population, already over 200 million in 2026. These three categories generally require special certifications or clinical validation — high barriers, and high premiums.

3. The asset-light path for emerging brands

A decent cosmetics production line costs tens of millions or even hundreds of millions upfront — something small and mid-sized brands simply cannot carry. Outsourcing R&D and production wholesale to an ODM, and pouring limited resources into brand and channel, has become the default choice for most startup teams.

III. Why efficacy skincare OEM became standard for brands

Traditional OEM only "produces to formula," while ODM covers the full chain of formula R&D, efficacy validation, packaging design and compliance filing. For a brand, the value of efficacy skincare OEM is not just saving one production line — it is outsourcing the very act of "building a product from zero to one that can legitimately claim efficacy." Especially in categories that require a special cosmetics registration certificate (special permit), such as brightening and sunscreen, running the filing yourself is long and costly; handing it to a factory with a reserve of special permits often more than halves the time to market.

For example: a new brand wanting to do "brightening and spot-fading" would, doing it alone from formula, testing, human efficacy evaluation to registration, typically measure the cycle in years; choosing a contract manufacturer that already has a special-permit filing system for customized development lets it reuse compliant assets and validation data, freeing energy for positioning and marketing. This is also why more and more brands choose their manufacturing partner like a "co-founding team."

IV. Three partnership paths to capture the dividend

Path 1: Co-create in R&D, don't just drop off a formula

Don't treat the contract manufacturer as "processing on supplied materials." Good collaboration means the brand brings consumer insight and selling-point ideas while the factory brings its ingredient library, formula experience and efficacy-evaluation capability to refine together. For a compound need like "late-night dullness + early aging," for instance, the factory can use microencapsulation to stabilize unstable actives and directional transdermal delivery to raise utilization — things a brand cannot simply dream up.

Path 2: Lock onto special-permit qualifications, stake out high-barrier categories

Sunscreen and brightening/spot-fading are special cosmetics that require a registration certificate before any claim. Securing a factory with a reserve of special permits and filing experience in advance is like claiming the compliance moat early. Combinations like "triple-certified brightening" (special cosmetics registration + patent + clinical validation) satisfy regulators while giving the brand hard currency for its efficacy story. For details on special-permit manufacturing, see our OEM service page.

Path 3: Flexible supply, small batches and fast reorders to keep pace

Hot ingredients and niche tracks come and go fast, and betting on large inventory is highly risky. A flexible supply chain supports small-batch sampling and rapid reorders, letting brands experiment with lower inventory. This matters enormously for fast-paced channels like Douyin and private domains — a factory that can launch in two weeks and reorder in a month is worth more than one quoting three cents cheaper but delivering in two months.

V. Choosing an ODM: pitfalls to avoid

VI. How DEVA's ODM creates value for brands

Back to execution. Guangzhou Tianxi Biological Technology Co., Ltd. has focused on R&D and smart manufacturing of "fresh & active efficacy cosmetics" for nearly 20 years, upholding the philosophy of "fresh & active, real efficacy." Relying on its "Two Academies, Two Stations, Three Centers" R&D system, its efficacy skincare OEM covers the full chain from formula to compliance. Its product lines land squarely on today's hottest directions: infant-grade age-segmented skincare, guo-gan teen oil-control and acne care, pure peony-flower extract for sensitive skin, the "Changbai" triple-certified brightening series, and full-spectrum sunscreen with special permits — paired with microencapsulation and directional transdermal delivery, giving brands a package of "ready track + ready efficacy proof."

For brands going global, DEVA operates a factory in Indonesia that supports BPOM registration and HALAL certification, helping brands enter the ASEAN market at lower compliance cost. Whether you do infant skincare or sunscreen special-permit OEM, you'll find matching R&D and capacity at DEVA. For more ways to work together, reach us through our inquiry contact.

VII. Frequently asked questions (FAQ)

Q1: For a new brand's first efficacy skincare product, which category is the safer entry?
A: Start with foundational efficacies like repair and moisturizing, which carry relatively low compliance risk and high repurchase, then move to special-permit categories like brightening and sunscreen after validating supply chain and channel.

Q2: How long does a special permit take, and how can a manufacturer help?
A: Special cosmetics registration typically takes months or longer. A factory with reserved permits and filing experience can reuse existing validation data and speed up documentation, significantly shortening time to market.

Q3: Will a factory reject small trial batches?
A: It depends on the factory's positioning. ODMs with flexible lines accept small batches and fast reorders because that is also how most emerging brands work — the key is confirming the minimum order quantity up front.

Q4: What matters most when exporting to Southeast Asia?
A: Regulations differ greatly by country. Markets like Indonesia require BPOM registration, and some categories need HALAL certification; choosing a factory with local compliance experience saves a lot of detours.